RX614 RX614 Pill - blue capsule/oblong, 14mm
Pill with imprint RX614 RX614 is Blue, Capsule/Oblong and has been identified as Doxycycline Monohydrate 50 mg. It is supplied by Ranbaxy Pharmaceuticals Inc.
Doxycycline is used in the treatment of Acne; Actinomycosis; Amebiasis; Anthrax; Ocular Rosacea and belongs to the drug classes miscellaneous antimalarials, tetracyclines. There is positive evidence of human fetal risk during pregnancy. Doxycycline 50 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for RX614 RX614
Doxycycline Monohydrate
- Imprint
- RX614 RX614
- Strength
- 50 mg
- Color
- Blue
- Size
- 14.00 mm
- Shape
- Capsule/Oblong
- Availability
- Prescription only
- Drug Class
- Miscellaneous antimalarials, Tetracyclines
- Pregnancy Category
- D - Positive evidence of risk
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Ranbaxy Pharmaceuticals Inc.
- National Drug Code (NDC)
- 63304-0614
- Inactive Ingredients
-
ferrosoferric oxide,
propylene glycol,
potassium hydroxide,
shellac,
magnesium stearate,
sodium starch glycolate type A potato,
D&C Red No. 28,
FD&C Blue No. 1,
titanium dioxide,
silicon dioxide,
microcrystalline cellulose
Note: Inactive ingredients may vary.
More about doxycycline
- Check interactions
- Compare alternatives
- Pricing & coupons
- Reviews (1,624)
- Drug images
- Side effects
- Dosage information
- Patient tips
- During pregnancy
- Support group
- Drug class: miscellaneous antimalarials
- Breastfeeding
- En español
Patient resources
- Doxycycline drug information
- Doxycycline Delayed-Release Tablets
- Doxycycline Tablets and Capsules
- Doxycycline Capsules (Rosacea)
- Doxycycline Syrup
Other brands
Vibramycin, Monodox, Doxy 100, Doryx, ... +8 more
Professional resources
- Doxycycline monograph
- Doxycycline (Topical) (AHFS Monograph)
- Doxycycline Hyclate (EENT) (AHFS Monograph)
- Doxycycline (FDA)
- Doxycycline Delayed Release Capsule (FDA)
Other brands
Vibramycin, Monodox, Doxy 100, Doryx, ... +7 more
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.